Peppermint Oil Pharmacokinetics/Dynamics

  • End date
    Mar 26, 2023
  • participants needed
  • sponsor
    Baylor College of Medicine
Updated on 26 January 2021
functional abdominal pain


In children 7-12 years of age with functional abdominal pain (n=42) determine:

Aim 1 - To examine and characterize the threshold of the exposure (PK) vs. response (PD) relationship of PMO (menthol)

Aim 2 - PD of PMO as assessed by:

  1. Microbiome composition (16S RNA sequencing)
  2. Transit rate/contractile activity (using the SmartPill) Aim 3 - Evaluate the potential association between PD response and clinical symptoms (abdominal pain and stooling pattern via validated diary), psychosocial distress (anxiety, depression, somatization), and characterize potential side effects (questionnaire)


An initial single-dose PK study will be carried out. Forty-two children (n=21 per dose) will be randomized to receive approximately 10.9 mgkg-1d-1 of PMO or to receive approximately 18.2 mgkg-1d-1 (1.67-fold the median dose).

Following the single-dose PK study, a PD study will be carried out wherein the subjects will receive their assigned dose of PMO for 7 days.

At baseline (before the PK study) and after the PK study (i.e., during the PD study), subjects will keep a pain and stooling diary, collect stool for microbiome analysis, and swallow a SmartPill to measure gut motility and transit time. At baseline only, anxiety, depression, somatization will be measured. During the PD study, any side effects will be recorded.

Condition Pain, Abdominal Pain, Post-Surgical Pain, Pain (Pediatric)
Treatment peppermint oil
Clinical Study IdentifierNCT04497870
SponsorBaylor College of Medicine
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

Children ages 7-12 years who are able to assent to the procedures
Able to complete the diaries which have been validated for use in this age range
The history and medical evaluation reveal no organic reason for the abdominal pain
The child has abdominal pain that meets the definition of FAP according to pediatric Rome IV
Ability to understand study procedures and to comply with them for the entire length of the study
Childrens' body weights will not vary by more than 10-15 kg (so that dose per kg is comparable within the two dosing groups)

Exclusion Criteria

Past bowel surgery
Documented GI disorders (e.g., Crohn's disease)
A serious chronic medical condition (e.g., diabetes)
A weight and/or height < 2 SD for age
Chronic conditions with GI symptoms (e.g., cystic fibrosis)
Autism spectrum disorder, significant developmental delay, psychosis, depression, or a history of bipolar disorder
Antibiotic/probiotic treatment within 2 mo
Allergy/sensitivity to PMO or its ingredients
Inability to swallow the PMO capsule or the SmartPill
Inability to speak English - testing materials are available only in this language
Unable to discontinue laxative, prokinetic, or neuromodulator from 3 wk prior to Visit 1 through the end of the study
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note